Publication | Closed Access

Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols

Tumor BiologyCancer ImmunosurveillanceCombinatorial Treatment ProtocolsMedicineT-regulatory CellImmunologyImmunoeditingImmune Checkpoint InhibitorCell BiologyImmune Cell TherapyImmunotherapyOncologyCell TransplantationTumor MicroenvironmentCancer Research